Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Ichikawa

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Biomedical Reports|October 3, 2022
Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis CTatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, et al.
World Journal of Gastrointestinal Endoscopy|March 22, 2013
Novel serine/threonine kinase 11 gene mutations in Peutz-Jeghers syndrome patients and endoscopic managementHiroyuki Yajima, Hajime Isomoto, Hiroaki Nishioka, et al.
Digestive Diseases and Sciences|June 8, 2011
Enhanced expression of CXCL13 in human Helicobacter pylori-associated gastritisYujiro Nakashima, Hajime Isomoto, Kayoko Matsushima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Hepatitis C virus kinetics during the first phase of pegylated interferon-alpha-2b with ribavirin therapy in patients with living donor liver transplantationTatsuki Ichikawa, Kazuhiko Nakao, Hisamitsu Miyaaki, et al.
World Journal of Hepatology|December 10, 2025
Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver diseaseTatsuki Ichikawa, Satoshi Miuma, Mio Yamashima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2006
The impact of newer treatment modalities on survival in patients with hepatocellular carcinomaNaota Taura, Keisuke Hamasaki, Kazuhiko Nakao, et al.
Oncogene|March 19, 2003
Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivationMasaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa, et al.
International Journal of Oncology|June 26, 2008
Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesisTakashi Goto, Hiroki Ishikawa, Kojiro Matsumoto, et al.
Biomedical Reports|August 8, 2025
Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort studyTatsuki Ichikawa, Satoshi Miuma, Mio Yamashima, et al.
Biomedical Reports|August 20, 2024
Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver diseaseTatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Biomedical Reports|October 3, 2022
Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis CTatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, et al.
World Journal of Gastrointestinal Endoscopy|March 22, 2013
Novel serine/threonine kinase 11 gene mutations in Peutz-Jeghers syndrome patients and endoscopic managementHiroyuki Yajima, Hajime Isomoto, Hiroaki Nishioka, et al.
Digestive Diseases and Sciences|June 8, 2011
Enhanced expression of CXCL13 in human Helicobacter pylori-associated gastritisYujiro Nakashima, Hajime Isomoto, Kayoko Matsushima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Hepatitis C virus kinetics during the first phase of pegylated interferon-alpha-2b with ribavirin therapy in patients with living donor liver transplantationTatsuki Ichikawa, Kazuhiko Nakao, Hisamitsu Miyaaki, et al.
World Journal of Hepatology|December 10, 2025
Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver diseaseTatsuki Ichikawa, Satoshi Miuma, Mio Yamashima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2006
The impact of newer treatment modalities on survival in patients with hepatocellular carcinomaNaota Taura, Keisuke Hamasaki, Kazuhiko Nakao, et al.
Oncogene|March 19, 2003
Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivationMasaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa, et al.
International Journal of Oncology|June 26, 2008
Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesisTakashi Goto, Hiroki Ishikawa, Kojiro Matsumoto, et al.
Biomedical Reports|August 8, 2025
Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort studyTatsuki Ichikawa, Satoshi Miuma, Mio Yamashima, et al.
Biomedical Reports|August 20, 2024
Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver diseaseTatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, et al.
Pageof 15